SOURCE: Xtalks

Xtalks Webinars

June 23, 2016 08:13 ET

New Webinar Hosted by Xtalks to Examine Current Post-Approval Research Strategies for Pharmaceutical, Biotechnology and Medical Device Companies

Conducting Post-Approval Research Requires a Unique Mindset and Specialized Infrastructure. Do You Have What It Takes?

TORONTO, ON--(Marketwired - June 23, 2016) - During the webinar, industry expert Kirsten Colling, Senior Director of Global Operations at Bioclinica Post-Approval Research, will outline how not all post-approval research studies are the same, and the importance of each study being reviewed in order to ensure that the correct strategies are applied for various types of post-approval research.

While post-approval research is evolving rapidly, and these studies are becoming far more complex, our knowledge in implementing and conducting such studies has not evolved with the same pace. There are fundamental differences in conducting research in pre-market randomized controlled trials (RCT) versus post-approval research. These differences are not only in the study intent and objectives but the operations and conduct. Applying appropriate regulatory regulations for post-approval research is an art not a science. Often the industry will see the same regulatory rigor applied to post-approval research as RCTs which leads to inappropriate design and execution. Consequently, these studies become cost prohibitive.

Post-approval research studies are often massive and global with tens of thousands of patients and thousands of physicians. Managing such studies requires uniquely different operational infrastructure as well as processes. SOPs must be specially designed to support such studies and the operational mindset must be geared towards how to effectively manage research naïve physicians and implement patient centric approaches. Utilizing smart technology in not only desirable but necessary to contain study costs. By deploying such technology, companies will minimize resource burn and decrease costs.

Join the live broadcast on Thursday, July 14, 2016 at 12pm EDT. For more information or to register for this complimentary event, visit: Conducting Post-Approval Research Requires a Unique Mindset and Specialized Infrastructure. Do You Have What It Takes?

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/6/23/11G104036/Images/Bioclinical_TransparentLogo_200-336767260496a206aa017efc5a3851ae.jpg

Contact Information